Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

Clinical trial NCT04542824 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04542824
Sponsor: Genmab
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma High-grade B-cell Lymphoma Primary Mediastinal Large B Cell Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma

Start date: 2020-08-20
Primary completion: 2027-09-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.